GSK

GSK spinning out VC arm SR One
BioCentury
Mon, 01/28/19 - 10:00 am
GSK
SR One
spinoffs
venture capital
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
Mon, 02/4/19 - 02:45 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
GSK closes acquisition of Tesaro for $5.1bn
Pharmaceutical Business Review
Wed, 01/23/19 - 10:39 am
GSK
Tesaro
M&A
oncology
GSK Chairman Sir Philip Hampton Steps Down Ahead of Company Split
BioSpace
Mon, 01/21/19 - 10:55 am
GSK
Philip Hampton
restructuring
Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?
Yahoo/Motley Fool
Sun, 01/20/19 - 03:20 pm
drug pricing
Big Pharma
Amgen
AstraZeneca
Pfizer
GSK
Merck
Gilead
Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there's no connection
Fierce Pharma
Wed, 01/16/19 - 12:06 am
GSK
Shingrix
vaccines
drug shortage
government shutdown
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
Fri, 01/11/19 - 10:25 am
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
JPM19: A biotech's M&A invitation, Editas' next CRISPR step and more from day 3
Biopharma Dive
Thu, 01/10/19 - 12:31 pm
Editas
CRISPR
GSK
Tesaro
Clovis Oncology
M&A
AbbVie
JPMHC 2019
Class Action Lawsuit Aims to Halt GSK Acquisition of Tesaro
BioSpace
Tue, 01/8/19 - 07:10 pm
GSK
M&A
Tesaro
shareholders
Pfizer and GSK Spin off Consumer Health Divisions Into a New Joint Venture
BioSpace
Wed, 12/19/18 - 11:46 am
Pfizer
GSK
M&A
spinoffs
consumer health
Tesaro execs split $304M windfall from $5.1B GlaxoSmithKline buyout
Endpoints
Mon, 12/17/18 - 09:14 am
Tesaro
executive pay
M&A
GSK
Anatomy of a long-delayed biotech buyout: With its stock price beaten down, abandoned by potential bidders, Tesaro wound up in GSK’s eager arms
Endpoints
Sat, 12/15/18 - 11:44 pm
M&A
Tesaro
Zejula
GSK
Biktarvy's success raises doubts about ViiV's 'new era' of HIV treatment
Biopharma Dive
Wed, 12/12/18 - 12:07 am
GSK
ViiV Healthcare
HIV
GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'
Fierce Pharma
Tue, 12/11/18 - 10:16 am
GSK
shingles
vaccines
Shingrix
drug shortages
Should You Be Worried About the Return of Big Pharma Deals?
Motley Fool
Tue, 12/4/18 - 11:27 am
GSK
Tesaro
M&A
Big Pharma
JNJ
Argenx
GSK Pays $5.1B For Tesaro, Setting Up “PARP” Battle With Rival AstraZeneca
Xconomy
Mon, 12/3/18 - 10:11 am
GSK
M&A
Tesaro
PARP inhibitors
Zejula
AstraZeneca
Crown Laboratories buys select OTC consumer healthcare brands from GSK
Pharmaceutical Business Review
Mon, 12/3/18 - 10:10 am
Crown Laboratories
GSK
OTC
M&A
GlaxoSmithKline weighs plan to develop vaccine against fast-spreading gonorrhea: report
Fierce Pharma
Tue, 11/27/18 - 12:21 pm
GSK
Bexsero
vaccines
STD
gonorrhea
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
BioSpace
Fri, 11/23/18 - 01:08 pm
GSK
JNJ
Novartis
Merck KGaA
Sanofi
Takeda
developing countries

Pages